The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Toxicity and outcome of anti-GD2 antibody ch14.18/CHO in front-line, high-risk patients with neuroblastoma: Final results of the phase III immunotherapy randomisation (HR-NBL1/SIOPEN trial).
 
Ruth Ladenstein
Honoraria - Apeiron Biologics; Boehringer Ingelheim
Consulting or Advisory Role - Apeiron Biologics (Inst); Boehringer Ingelheim (Inst)
Research Funding - Apeiron Biologics (Inst)
Patents, Royalties, Other Intellectual Property - Apeiron Biologics (Inst)
Expert Testimony - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics
 
Ulrike Poetschger
No Relationships to Disclose
 
Juliet Gray
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Dominique Valteau-Couanet
No Relationships to Disclose
 
Roberto Luksch
No Relationships to Disclose
 
Victoria Castel
No Relationships to Disclose
 
Isaac Yaniv
Travel, Accommodations, Expenses - Apeiron Biologics
 
Genevieve Laureys
No Relationships to Disclose
 
Martin Elliott
No Relationships to Disclose
 
Jean Marie Michon
No Relationships to Disclose
 
Cormac Owens
No Relationships to Disclose
 
Toby Trahair
No Relationships to Disclose
 
Godfrey Chi Fung Chan
Patents, Royalties, Other Intellectual Property - The University of Hong Kong
 
Ellen Ruud
No Relationships to Disclose
 
Henrik Schroeder
No Relationships to Disclose
 
Maja Beck Popovic
No Relationships to Disclose
 
Evgenia Glogova
No Relationships to Disclose
 
Guenter Schreier
No Relationships to Disclose
 
Hans Loibner
Employment - Apeiron Biologics
Leadership - Apeiron Biologics
Stock and Other Ownership Interests - Apeiron Biologics
Honoraria - Apeiron Biologics
Consulting or Advisory Role - Apeiron Biologics
Patents, Royalties, Other Intellectual Property - Apeiron Biologics
Travel, Accommodations, Expenses - Apeiron Biologics
 
Holger N. Lode
Consulting or Advisory Role - Apeiron Biologics